NON-INVASIVE BGM

Strategic Alliance: Suigen Healthcare AG and iGluco TECH SA:

At Suigen Healthcare, we are committed to driving breakthrough innovations in diabetes management. As part of this mission, we have formed a strategic alliance with iGluco TECH SA, a pioneering company based in Spain that has launched the world’s first non-invasive glucose monitoring device.

About iGluco TECH SA

iGluco SA is at the forefront of glucose monitoring technology, continuously researching and developing new, non-invasive solutions to improve diabetes care and patient experience. Their cutting-edge technology eliminates the need for painful finger pricks, providing accurate, real-time glucose measurements without invasive procedures.

Suigen Healthcare’s Role in the Partnership

Through this alliance, Suigen Healthcare supports iGluco TECH SA in key strategic areas, including:

 Business Development – Expanding market reach, establishing commercial partnerships, and driving adoption in global healthcare ecosystems.

 Project Management – Overseeing the execution of research, development, and implementation strategies to accelerate the advancement of next-generation glucose monitoring technologies.

 Funding Investment Strategy – Assisting in securing funding opportunities, forging connections with investors, and ensuring long-term financial sustainability for iGluco’s innovations.

 Intellectual Property (IP) Management – Strengthening patent protection, navigating regulatory landscapes, and safeguarding proprietary technology in the competitive healthcare market.

Together, Suigen Healthcare and iGluco TECH SA are transforming diabetes management, making non-invasive glucose monitoring a reality and paving the way for future advancements in metabolic health technologies.